including its digital stethoscopes and AI technology. In addition to the Low EF AI, the company also has FDA-cleared algorithms for detecting atrial fibrillation and structural heart murmurs.

Astellas has licensed rights to a smart stethoscope device developed by Eko Health, that it will use as part of a digital therapeutic (DTx) approach to heart failure. The plan is to combine the ...